// App-Quantinova.ai

3815 : Cyclin-dependent kinase 9: a potential therapeutic target for esophageal adenocarcinoma

Researchers

Presenter

  • Zhimin Tong

Principal Investigators

  • Devkumar Chatterjee

  • Defeng Deng

  • Omkara Veeranki

  • Alicia Mejia

  • Jaime Rodriguez

  • Jaffer Ajani

  • Wayne Hofstetter

  • Steven Lin

  • Sushovan Guha

  • Scott Kopetz

  • Sunil Krishnan

  • Dipen Maru

Medical Centers

  • Department of Radiology, MD Anderson Cancer Center, Houston, TX

  • Department of Radiology, MD Anderson Cancer Center, Houston, TX

  • Department of Radiology, MD Anderson Cancer Center, Houston, TX

  • Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Gastrointestinal Medical Oncology, MD Anderson Cancer Center, Houston, TX

  • Department of Thoracic & Cardiovascular Surgery, MD Anderson Cancer Center, Houston, TX

  • UT Health Science Center and Medical School at Houston, Houston, TX.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Esophageal Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved